Transaction DateRecipientSharesTypePriceValue
9th July 2020Elias Vamvakas20,140Disposition due to a tender of shares in a change of control transaction$0.06$1,180.20
9th July 2020Elias Vamvakas130,813Disposition due to a tender of shares in a change of control transaction$0.06$7,665.64
9th July 2020Elias Vamvakas32,000Disposition due to a tender of shares in a change of control transaction$0.06$1,875.20
9th July 2020Michael Marquez500Disposition due to a tender of shares in a change of control transaction$0.06$29.30
9th July 2020Richard Lindstrom14,778Disposition due to a tender of shares in a change of control transaction$0.06$865.99
9th July 2020Richard Lindstrom6,000Disposition due to a tender of shares in a change of control transaction$0.06$351.60
9th July 2020Paul Karpecki102,200Disposition due to a tender of shares in a change of control transaction$0.06$5,988.92
9th July 2020Joseph Jensen22,540Disposition due to a tender of shares in a change of control transaction$0.06$1,320.84
9th July 2020Anthony E Altig8,833Disposition due to a tender of shares in a change of control transaction$0.06$517.61
Tearlab
Tearlab logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.


TearLab Corp. engages in the development and marketing of a tear testing platform. The company was founded by Benjamin D. Sullivan in 1996 and is headquartered in Escondido, CA.


Ticker: TEAR
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 1299139
Employees: 40
Exchange: US OTC
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals